Loading...
OTCM
BLGO
Market cap59mUSD
Dec 05, Last price  
0.19USD
1D
0.00%
1Q
-13.29%
Jan 2017
-77.04%
Name

BioLargo Inc

Chart & Performance

D1W1MN
OTCM:BLGO chart
P/E
P/S
3.36
EPS
Div Yield, %
Shrs. gr., 5y
14.41%
Rev. gr., 5y
57.05%
Revenues
18m
+45.37%
0080,0000138,133156,761156,18965,542167,946111,547127,582281,106516,2131,364,0001,861,0002,432,0002,531,0005,884,00012,230,00017,779,000
Net income
-2m
L-31.45%
-1,187,301-1,310,706-5,259,390-7,142,750-15,612,532-5,742,341-3,954,389-5,333,986-2,528,323-3,692,116-5,055,976-7,839,731-9,117,304-10,221,000-14,749,000-10,466,000-7,377,000-4,496,000-3,504,000-2,402,000
CFO
-3m
L+35.56%
-825,008-1,315,628-1,287,525-1,899,034-1,369,394-1,296,556-1,716,324-2,032,804-1,212,252-1,718,621-1,883,342-3,720,912-4,283,015-3,891,000-4,422,000-4,154,000-3,937,000-2,762,000-2,365,000-3,206,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. It holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. The company's products include Advanced Oxidation system, a water treatment device that generates a series of oxidative and energetic species of iodine and other molecules; Aqueous Electrostatic Concentrator, a water treatment system that removes per- and poly-fluoroalkyl substances from water; CupriDyne Clean industrial products, which reduce and eliminate tough odors and volatile organic compounds in various industrial settings; and advanced wound care products. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
IPO date
Dec 12, 1991
Employees
32
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT